| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GTF2I | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | GPR176 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | ATP5I | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | GLYATL1P3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | MLEC | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | UBL3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CSDC2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | BEX3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | FUT2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PISD | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
